Name: Cardiosolutions Inc.
Location: West Bridgewater, Massachusetts
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Industry: Medical Devices
Products: Developing PerCu-Pro System that is an implanted device to percutaneously repair the mitral valve to prevent blood leaking into the left ventricle (also known as mitral valve regurgitation); the Dexterity Steerable Introducer is a flexible tool that allows physicians to reach difficult-to-access regions of the heart.
Money raised: $14.8 million (previous filings show that the company has raised at least $10.7 million in earlier rounds).
How it will be used: Company didn’t immediately return a call in response to that question.
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Investors: BioVentures Investors.
Management team: Steven Tallarida, president and chairman; Jon Wilson, chief operating officer; Ross Garofalo, vice president and chief financial officer.
Market size: Several companies note that about 4 million Americans have leaky mitral heart valves.
Competitors: Edwards Lifesciences, QuantumCor, Mitralign, MiCardia among others
[Photo Credit: Flickr user amagill]
